Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prolymphocytic leukaemia (author's transl)].

K Abbrederis, G Michlmayr, F Schmalzl

    Deutsche Medizinische Wochenschrift (1946)
    |January 5, 1979
    PubMed
    Summary

    Prolymphocytic leukemia, a rare lymphoid malignancy, presents differently in B-cell and T-cell types. Early diagnosis and splenectomy may improve outcomes for B-cell prolymphocytic leukemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    In-utero fetal resuscitation during fetal blood transfusion for severe fetal erythroblastosis developed after chorionic villus sampling.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
    Same author

    Virtual reality cricothyrotomy - a case-control study on gamification in emergency education.

    BMC medical education·2024
    Same author

    In-situ alignment of 3D printed anisotropic hard magnets.

    Scientific reports·2022
    Same author

    FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    The Danish STR sequence database: duplicate typing of 363 Danes with the ForenSeq™ DNA Signature Prep Kit.

    International journal of legal medicine·2018

    Area of Science:

    • Hematology
    • Oncology
    • Immunology

    Background:

    • Prolymphocytic leukaemia (PLL) is a rare, aggressive lymphoid malignancy.
    • Distinguishing between B-cell and T-cell subtypes is crucial for prognosis and treatment.

    Observation:

    • Two cases of prolymphocytic leukaemia in elderly women are presented.
    • Morphological, immunological, and cytochemical analyses were performed.
    • Acid phosphatase activity was a significant cytochemical marker.

    Findings:

    • One patient had B-cell prolymphocytic leukaemia, the other T-cell prolymphocytic leukaemia.
    • The patient with T-cell PLL died within three months.
    • The patient with B-cell PLL survived over 16 months, showing improvement after splenectomy.

    Implications:

    • Splenectomy may be a beneficial treatment for B-cell prolymphocytic leukaemia.
    • This study highlights the importance of subtype differentiation in PLL management.
    • Further research into optimal therapeutic strategies for PLL is warranted.

    Related Experiment Videos